BABA
Alibaba Group Holding Limited
BABA has lower modeled downside risk, despite its lower overall score.
RH
Rh
RH has the edge over BABA overall, supported by stronger valuation and stronger fundamentals.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
RH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
RH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA has the edge over RH in the historical PE scenario, which offers more potential upside but is not a forecast.
RH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $80.52 | -38% |
| Forward | 17x | $129 | — |
| Current | 23x | $129 | — |
| Fair | 31x | $174 | +35% |
| Expensive | 59x | $332 | +157% |
Historical ranges are pointers, not guarantees.
RH's PE is in its cheap range at 23x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
RH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for RH, with profitability improving. However, they disagree widely on these estimates.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
RH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.76 | +38% |
| Q3 2026 | $5.62 | +4.3% |
| Q2 2026 | $5.18 | +23% |
| Q1 2026 | $6.31 | +74% |
| Q4 2025 | $5.56 | +46% |
| Q3 2025 | $5.39 | +164% |
| Q2 2025 | $4.22 | +6.8% |
| Q1 2025 | $3.62 | -39% |
| Q4 2024 | $3.82 | -59% |
RH has the edge over BABA on earnings, with more consistent year-over-year improvement.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over RH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
RH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $922.2M | +2.6% |
| Q2 2026 | $800.3M | -1.7% |
| Q1 2026 | $842.6M | +3.7% |
| Q4 2025 | $883.8M | +8.9% |
| Q3 2025 | $899.2M | +8.4% |
| Q2 2025 | $814M | +12% |
| Q4 2024 | $811.7M | +8.1% |
| Q3 2024 | $829.7M | +3.6% |
RH's revenue has held roughly level: $922M last quarter, up 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -2.7 points |
| Q2 2026 | 4.3% | -2.6 points |
| Q1 2026 | 11% | +2.8 points |
| Q4 2025 | 12% | -0.5 points |
| Q3 2025 | 14% | +2.7 points |
| Q2 2025 | 6.9% | -0.6 points |
| Q1 2025 | 8.7% | N/A |
| Q4 2024 | 13% | +5.7 points |
RH has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
RH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $99.6M | +23% |
| Q2 2026 | $13.3M | -61% |
| Q1 2026 | $54.6M | +$124.3M |
| Q4 2025 | $83M | +$179M |
| Q3 2025 | $80.7M | +$118.6M |
| Q2 2025 | $34.1M | +$44.2M |
| Q1 2025 | -$69.7M | +$181.8M |
| Q4 2024 | -$96M | -646% |
RH has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
RH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.4% | +824K shares |
| 1 year | -0.3% | -68K shares |
| 3 years | -13% | -3.1M shares |
| 5 years | -37% | -11.5M shares |
| Available history | -19% | -4.5M shares |
RH has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q1 2024 | — |
| Q4 2023 | $44.6M |
| Q1 2023 | $713.6M |
| Q4 2022 | $31.7M |
| Q1 2020 | — |
| Q4 2019 | — |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
RH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.2x | Very low |
RH has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
RH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.3 | Neutral |
| Stochastic | 30.5 | Neutral |
RH's weekly RSI is 44 (neutral) and its Stochastic is 30 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over RH on valuation relative to its sector.
RH PE vs Consumer Cyclical Sector
| Metric | RH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 28% above |
| PE % | 32 | 47 | 15 pts below |
RH is trading at 23x earnings, a 28% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
RH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $127.4 | 1.4% above |
| 20 week MA | $148.5 | 13% below |
| 50 week MA | $156.8 | 18% below |
| 100 week MA | $198.9 | 35% below |
| 200 week MA | $243.8 | 47% below |
RH has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
RH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $214.9 | $475.7 | +121% |
| 2021 | $475.7 | $546.1 | +15% |
| 2022 | $546.1 | $264.4 | -52% |
| 2023 | $264.4 | $291.5 | +10% |
| 2024 | $291.5 | $398.1 | +37% |
| 2025 | $398.1 | $185.7 | -53% |
| 2026 YTD | $185.7 | $129.2 | -30% |
RH has the edge over BABA on returns for 2026, with the stronger performance.